Last edition
News about "Glenmark Pharmaceutical"
US FDA issues warning letter to Glenmark's Goa facility
The US drug regulator inspected Glenmark's Goa facility in May 2022 and issued an Official Action Indicated (OAI)<br />
Glenmark Pharmaceutical | 25/11/2022 | By Sudeep Soparkar | 233
Glenmark launches Type 2 diabetes drugs in India
The company has introduced 8 different combinations of sitagliptin-based drugs under the brand name SITAZIT<br />
Glenmark Pharmaceutical | 07/07/2022 | By Sudeep Soparkar | 439
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy